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Brucella species are highly monomorphic, with minimal genetic variation among species, hindering the
development of reliable subtyping tools for epidemiologic and phylogenetic analyses. Our objective was to
compare two distinct multiple-locus variable-number tandem-repeat analysis (MLVA) subtyping methods on
a collection of 101 Brucella melitensis isolates from sporadic human cases of brucellosis in Egypt (n  83),
Qatar (n 17), and Libya (n 1). A gel-based MLVA technique, MLVA-15IGM, was compared to an automated
capillary electrophoresis-based method, MLVA-15NAU, with each MLVA scheme examining a unique set of
variable-number tandem repeats. Both the MLVAIGM and MLVANAU methods were highly discriminatory,
resolving 99 and 101 distinct genotypes, respectively, and were able to largely separate genotypes from Egypt
and Qatar. The MLVA-15NAU scheme presented higher strain-to-strain diversity in our test population than
that observed with the MLVA-15IGM assay. Both schemes were able to genetically correlate some strains
originating from the same hospital or region within a country. In addition to comparing the genotyping abilities
of these two schemes, we also compared the usability, limitations, and advantages of the two MLVA systems
and their applications in the epidemiological genotyping of human B. melitensis strains.
Brucellosis is a common zoonotic disease causing infections
in economically important livestock, such as cattle, goats,
sheep, and pigs (22). In humans, this highly diverse illness, also
known as Malta or undulant fever, initially presents as a fever,
malaise, and myalgia and may later develop into a chronic
illness affecting various organs and tissues (21, 25). Brucellosis
is usually transmitted to humans through consumption of con-
taminated and untreated milk products or by direct contact
with infected animals. There are nine phenotypically recog-
nized species in the Brucella genus: Brucella melitensis, B. abor-
tus, B. suis, B. ovis, B. canis, and B. neotomae; two new marine
species, B. ceti and B. pinnipedialis (11); and B. microti (27),
isolated from the common vole. Each species has distinctive
host preferences, pathogenicity, and epidemiology.
Although some developed countries have eradicated B.
abortus from cattle through vaccination campaigns, B. meliten-
sis, B. abortus, and B. suis remain the principal causes of human
brucellosis worldwide and are major public health problems,
primarily in developing countries (7). Brucellosis is prevalent
in the Mediterranean basin, the Middle East, Africa, Asia, and
areas of Latin America where people are economically depen-
dent on ruminant livestock (23, 28). Over the past decade, the
global epidemiology of human brucellosis has changed, due in
part to the implementation of national and international sur-
veillance programs, animal vaccination campaigns, and socio-
economic changes (22).
Current microbiological (4) and low-resolution molecular
typing methods are useful for identifying Brucella isolates and
determining species and biovar designations; however, they
have limited value for epidemiological trace-back investiga-
tions (6, 15). High-resolution genetic subtyping tools that could
provide important information about disease transmission pat-
terns and the molecular epidemiology of Brucella have been
difficult to develop and implement due to the genetically
monomorphic nature of Brucella species (12). Since the ge-
nome sequencing of four Brucella strains, B. abortus 2308 (26),
B. abortus 9-941 (14), B. suis 1330 (24), and B. melitensis 16M
(9), multilocus sequence typing (30) and multiple-locus vari-
able-number tandem-repeat analysis (MLVA) have been de-
veloped (16, 18, 29). Recent studies have shown that MLVA,
targeting multiple repeat regions with higher mutation rates
than other genomic markers, demonstrates higher genetic res-
olution when applied to Brucella species than assays targeting
other, more monomorphic molecular markers, such as the
outer membrane proteins (8, 10), the rpoB gene (19), and
insertion sequence regions (6).
In efforts to improve epidemiological surveillance and better
evaluate the utility of MLVA as a genotyping tool for Brucella
strains, the present study compared the discriminatory power
of two distinct MLVA methods (16, 18) in their ability to
distinguish geographic origin and resolve relationships within a
group of 101 human B. melitensis isolates from Egypt, Qatar,
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and Libya. Each MLVA typing technique examined polymor-
phisms at 15 different tandem repeat loci and employed two
different separation techniques. This study also compares the
usability of the two MLVA systems with regard to resources,
technological needs, scientific expertise, and time consump-
tion.
MATERIALS AND METHODS
The laboratory work for the gel-based MLVA (MLVA-15IGM [MLVA with 15
VNTR loci from the Institut de Ge´ne´tique et Microbiologie]) method was
performed at the NAMRU-3 laboratory facilities in Cairo, Egypt, while data
from the automated MLVA (MLVA-15NAU [MLVA with 15 VNTR loci from
Northern Arizona University]) assay were generated at the Centers for Disease
Control and Prevention (CDC) in Atlanta, GA.
Strain collection and template preparation. All 101 isolates used in the study
were of human origin and were identified as B. melitensis by the AMOS-PCR
assay (6). They originated from Egypt (n  83), Qatar (n  17), and Libya (n 
1). The Egyptian isolates were collected from an acute-febrile-illness laboratory-
based surveillance program implemented in a network of infectious-disease hos-
pitals throughout Egypt from 1999 to 2003 (1, 2), and the Libyan isolate was
recovered from a patient who traveled to Libya in 2006 (20). Human B. melitensis
isolates from Qatar, collected in August 2006, were donated by the Hamad
Medical Corporation, Doha, Qatar. The details of all isolates used in this study
are presented in Table 1. Bacterial isolates were cultured on Trypticase soy agar
with 5% sheep blood (BBL Microbiology Systems, Cockeysville, MD) at 37°C for
48 to 72 h. Total genomic DNA was extracted either using a Qiagen (Valencia,
CA) DNeasy blood and tissue kit by following the manufacturer’s protocol for
extraction of genomic DNA from gram-negative bacteria or by whole-cell lysis as
described by Gee et al. (13). The resulting lysates were stored at 20°C until
needed.
VNTR identification. The methods for selecting the variable-number tandem
repeats (VNTRs) used in the MLVA-15NAU and MLVA-15IGM techniques have
been described previously (16, 18). Table 2 shows the characteristics of the
VNTRs examined in both MLVA schemes. All primers used in this study were
obtained from Sigma Genosys (The Woodlands, TX).
VNTR analysis by the MLVA-15NAU technique. PCR amplification of 15
VNTR loci was performed as described previously (16) with the following
modifications. Forward primers were designed with either a 6-carboxyfluo-
rescein (FAM) or a HEX (N-hexachloro-fluorescein cyanoethyl phosphora-
midite) fluorescent label. Four multiplex PCRs (AI, BI, AII, and BII) were
performed to amplify 15 VNTR loci in a final volume of 10 l containing 1
PCR buffer, 2 mM MgCl2, 2 mM deoxynucleoside triphosphate mix, 0.04 U
Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA), 1 l DNA tem-
plate, and the following primer combinations: for AI, Bruce VNTR 21 F-HEX–
Bruce VNTR 21 R, Bruce VNTR 28 F-FAM–Bruce VNTR 28 R, and Bruce VNTR
16 F-HEX–Bruce VNTR 16 R; for BI, Bruce VNTR 03 F-FAM–Bruce VNTR 03
R, Bruce VNTR 20 F-HEX–Bruce VNTR 20 R, Bruce VNTR 31 F-FAM–Bruce
VNTR 31 R, Bruce VNTR 29 F-HEX–Bruce VNTR 29 R, and Bruce VNTR 33
F-FAM–Bruce VNTR 33 R; for AII, Bruce VNTR 14 F-FAM–Bruce VNTR 14 R,
Bruce VNTR 01 F-HEX–Bruce VNTR 01R, Bruce VNTR 07 F-FAM–Bruce
VNTR 07R, and Bruce VNTR 27 F-HEX–Bruce VNTR 27 R; and for BII, Bruce
VNTR 25 F-FAM–Bruce VNTR 25 R, Bruce VNTR 30 F-HEX–Bruce VNTR 30
R, and Bruce VNTR 02 F-FAM–Bruce VNTR 02 R. All reactions were performed
on an ABI 9700 thermocycler using the primer concentrations and thermal cycling
conditions reported previously (16).
Multiplex PCRs were pooled and diluted to a final dilution of 1:20 with molecular-
grade water. PCR products were denatured and resolved by capillary electrophoresis
on an ABI Prism 3130 automated fluorescent capillary DNA sequencer (Applied
Biosystems, Foster City, CA). Fragments were sized by comparison to a ROX
(carboxy-X-rhodamine)-labeled molecular ladder (MapMaker 1000; BioVentures
Inc., Murfreesboro, TN) with GeneMapper, version 4.0 (Applied Biosystems, Foster
City, CA), software. Appropriate VNTR designations of the fragments were as-
signed based on size calling through internal software binning capabilities.
VNTR analysis by the MLVA-15IGM technique. PCR primers for the MLVA-
15IGM technique have been reported previously (18). PCR amplification of the
15 VNTR loci occurred in a final volume of 25 l containing final concentrations
TABLE 1. Brucella melitensis isolates examined in this study
Country of origin and region Hospitallocationa
No. of
isolates
Egypt
Upper Egypt AST 5
SOH 2
QEN 4
ASW 7
Delta region SHB 16
ZAG 2
BEN 2
FAY 4
MAL 13
Cairo metropolitan area ABS 12
Coastal region ALX 15
PRS 1
Libya 1
Qatar Doha 17
Total 101
a ABS, Abbassia; ALX, Alexandria; ASW, Aswan; AST, Assiut; BEN, Benha;
FAY, Fayoum; MAL, Mahalla; PRS, Port Said; QEN, Qena; SHB, Shebin; SOH,
Sohag; ZAG, Zagazig.
TABLE 2. Characteristics of the VNTRs of the two MLVA-15 assays
MLVA-15NAU VNTR characteristics MLVA-15IGM VNTR characteristics
VNTR Genomic location inB. melitensis 16Ma
Repeat
size (bp)
No. of
alleles
Simpson’s
DI VNTR
Genomic location in
B. melitensis 16Ma
Repeat
size (bp)
No. of
alleles
Simpson’s
DI
BruceVNTR 16 339714–339950 8 4 0.49 Bruce 18 339785–339930 8 6 0.79
BruceVNTR 3 1249996–1250345 8 19 0.93 Bruce 07 1250093–1250250 8 8 0.77
BruceVNTR 28 1543941–1544121 8 9 0.79 Bruce 04 1543967–1544118 8 6 0.64
BruceVNTR 30 588314–588862 8 12 0.89 Bruce 09 588256–588681 8 9 0.82
BruceVNTR 27 548529–548905 8 9 0.84 Bruce 16 548571–548722 8 7 0.64
BruceVNTR 1 1938531–1938766 8 16 0.91 Bruce 21 328936–329083 8 2 0.18
BruceVNTR 2 1940192–1940778 8 17 0.92 Bruce 30 1505073–1505223 8 2 0.32
BruceVNTR 7 275628–275961 8 1 0 Bruce 06 1322650–1323057 134 2 0.20
BruceVNTR 21 574937–575041 6 2 0.06 Bruce 08 1134883–1135230 18 3 0.25
BruceVNTR 29 1915916–1916471 8 2 0.02 Bruce 11 211361–211617 63 1 0
BruceVNTR 31 344488–344993 5 6 0.77 Bruce 12 73619–74010 15 2 0.26
BruceVNTR 33 18596–19246 8 19 0.93 Bruce 42 424317–424855 125 4 0.25
BruceVNTR 14 396453–396581 9 1 0 Bruce 43 379369–379550 12 2 0.37
BruceVNTR 20 542226–542683 12 7 0.27 Bruce 45 233374–233524 18 2 0.37
BruceVNTR 25 216642–217140 15 1 0 Bruce 55 2066378–2066650 40 3 0.25
a Determined by NCBI nucleotide primer BLAST.
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of 2.5 mM MgCl2, 1 PCR buffer, 0.4 mM deoxynucleoside triphosphate nucle-
otide mixture, 1.25 U Taq DNA polymerase (Promega Corporation, Madison,
WI), 0.5 l DNA template, and 0.5 M forward and reverse primers. All PCRs
were performed on an MJ Research PTC-200 thermocycler with the thermal cycling
parameters reported previously. PCR amplicons were analyzed by gel electrophore-
sis as described previously (3, 18); agarose gels were then normalized; and band sizes
were estimated using BioNumerics version 4.61 (Applied Maths, Belgium). Band
size estimates were then converted to repeat units by following the published allele
numbering system that can be found at http://mlva.u-psud.fr/.
Analysis of MLVA data. Simpson’s index of diversity was calculated (5) for
each tandem-repeat locus based on a sample size of 101 B. melitensis isolates
(Table 2).
Data from both MLVA schemes were converted into character data sets within
the BioNumerics software (version 5.1; Applied Maths, Saint-Martens-Latem,
Belgium). Cluster analysis was performed on both data sets using the categorical
coefficient and UPGMA (unweighted-pair group method using arithmetic aver-
ages) analysis. The resulting UPGMA similarity matrices were used to generate
unrooted trees in FigTree, version 1.1.2 (http://tree.bio.ed.ac.uk/software/figtree)
(see Fig. 1 and 2).
RESULTS AND DISCUSSION
The two MLVA schemes evaluated in our study were se-
lected based on the availability of published MLVA schemes at
the time of the study design, their abilities to type human B.
melitensis isolates, and the availability of the resources, tech-
nology, and technical expertise required to perform the tech-
niques. As mentioned above, the gel-based MLVA assay was
carried out in Cairo, Egypt, and data from the automated
MLVA system were collected at the CDC in Atlanta, GA.
Thus far, there has been no study demonstrating the typing
abilities of different MLVA systems for a common collection of
Brucella isolates. The objective of our study was to compare the
resolving powers of two different MLVA techniques on a com-
mon collection of 101 clinical B. melitensis isolates from the
Middle East and to provide an assessment of the limitations,
advantages, and field applications of the two MLVA assays for
genotyping B. melitensis isolates.
The MLVA techniques compared in this study were devel-
oped for different purposes, which are reflected in the unique
combination of tandem-repeat markers that makes up each
scheme. Originally intended for forensic purposes, the MLVA-
15NAU assay contains 12 markers that have small repeat units
less than or equal to 8 bp; 8 of these markers have diversity
indexes (DIs) greater than 0.75 in our study. The MLVA-
15IGM assay, developed for epidemiological typing, contains
two panels: a panel of eight conserved markers with larger
repeat units (8 bp) (panel 1), exhibiting DIs less than 0.40 in
the strains we examined, and a panel of seven more-diverse
loci (panel 2) with small repeat units (8 bp).
FIG. 1. UPGMA analysis of 101 human B. melitensis isolates examined by the MLVA-15NAU scheme. Isolate designations indicate the country
of origin (E, Egypt; Q, Qatar; L, Libya), followed by the location within the country (ABS, Abbassia; ALX, Alexandria; ASW, Aswan; AST, Assiut;
BEN, Benha; FAY, Fayoum; MAL, Mahalla; PRS, Port Said; QEN, Qena; SHB, Shebin; SOH, Sohag; ZAG, Zagazig).
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Overall, the VNTR markers in the MLVA-15NAU assay pre-
sented a broader number of alleles and higher DIs than the
markers examined by the MLVA-15IGM scheme. Six of the 15
VNTR loci in the MLVA-15NAU scheme exhibited DIs of
0.80 for the 101 B. melitensis isolates examined, with allele
numbers ranging from 9 to 20 (Table 2). The Bruce VNTR 21
and Bruce VNTR 29 markers display very low genetic DIs of
0.06 and 0.02, respectively, while the Bruce VNTR 7, Bruce
VNTR 14, and Bruce VNTR 25 loci were monomorphic in the
strains we examined. The invariance we observed at these loci
is most likely due to the localized geographic origins of our
isolates and represents a level of strain-to-strain conservation
within a geographic area that can be better evaluated in a
larger population of isolates from similar locations. The mono-
morphic nature of the Bruce VNTR 7 and Bruce VNTR 25 loci
in the Middle Eastern strains could represent geographically
specific alleles, since these markers have been reported to
exhibit higher DIs in other B. melitensis strains, from the
United States (n  85) (16). The Bruce VNTR 14 locus is
consistently monomorphic in our strains and in other B.
melitensis strains examined by Huynh et al. (16) and could be
examined as a species-specific marker. Bruce VNTR 02, 20, 28,
31, and 33 were initially difficult to amplify in certain isolates.
However, all VNTR loci were successfully amplified in all
isolates except for Bruce VNTR 33 in isolate E5 and Bruce
VNTR 02 in isolate E53.
Only one of the 15 VNTR markers from the MLVA-15IGM
assay had a DI of 0.80 in the 101 strains we examined. The
Bruce 04, 07, 09, 16, and 18 VNTR markers exhibit the highest
DIs, ranging from 0.64 to 0.82, among the 15 markers (Table
2). The remaining 10 tandem-repeat markers ranged in diver-
sity from 0.18 to 0.37. The Bruce 11 VNTR marker is the only
monomorphic marker in the Middle Eastern strains we exam-
ined. Two of the 101 B. melitensis isolates (E21 and E26)
exhibited null alleles at the Bruce 09 locus; however, all other
markers were successfully amplified in all isolates.
The two MLVA schemes evaluated in this study were able to
correlate similar genetic relationships among the 101 B.
melitensis strains we examined. The MLVA-15NAU scheme,
exhibiting greater DIs, resolved 101 unique genotypes, while
the MLVA-15IGM assay discriminated 99 genotypes. Dendro-
grams generated by UPGMA clustering analysis (Fig. 1 and 2)
show similar groupings of B. melitensis strains by the MLVA
methods, such as the clustering of Qatar isolates Q1, Q3, and
Q5 with each other and the genetic similarity of Q6, Q7, and
Q13 strains to the Egyptian genotypes. Also, the Libyan strain
FIG. 2. UPGMA analysis of 101 human B. melitensis isolates examined by the MLVA-15IGM scheme. For isolate designations, see the legend
to Fig. 1.
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consistently clusters with the Egyptian genotypes by both
MLVA methods. Because none of the strains we examined
were epidemiologically linked, since they were sporadic cases
from various regions of Egypt and Qatar, we did not expect to
see a great deal of homogeneity by either MLVA method.
However, by the MLVA-15IGM scheme, two strains, E41 and
E42, which were isolated in the same hospital in Sohag, Egypt,
6 weeks apart from each other, had identical genotypes. Two
other strains, E61 and E62, isolated 2 years apart from each
other from another hospital, in Assiut, Egypt, also had identi-
cal genotypes. The same strains (E41 and E42; E61 and 62) did
not have identical genotypes by the MLVANAU assay but di-
verged by a mutation at one or both of the hypervariable
markers VNTR 01 and VNTR 33. By both MLVA schemes, it
is possible to see some strains originating from the same hos-
pital location or the same region (see Table 1 for regions)
within Egypt that have very similar but not identical genotypes,
which is expected for nonoutbreak strains.
The MLVA schemes evaluated in this study have different
logistical and technical requirements. The gel-based MLVA
method requires more time for typing from start to finish,
requires less technical expertise, and involves less-expensive
materials, although it does require BioNumerics software,
which is quite costly and requires technical training. The use of
multiple individual PCRs and agarose gels for typing one strain
is cumbersome and requires considerable subjectivity in the
stages of analysis of the raw data. The automated system is
much faster and has a high throughput capacity; however, the
instrumentation and proprietary reagents make this method
more expensive. The use of an automated sequencer and the
genetic analysis software require a skilled technician; however,
the data output is more reliable, and once properly optimized,
the method is very reproducible.
Both MLVA schemes examined in this study can be used to
epidemiologically type human B. melitensis strains and can be
used for high- and low-resolution typing by the inclusion and
exclusion of highly variable markers. We evaluated the two
MLVA schemes and compared their abilities to resolve rela-
tionships between geographically localized strains from the
Middle East, where B. melitensis is the primary etiologic agent
of human brucellosis. Other studies have looked at globally
diverse and localized Brucella strains using the MLVAIGM
assay (3, 17–19). However, it would be interesting to demon-
strate the capability of the MLVANAU method for differenti-
ating global genotypes in Brucella species. Although we cur-
rently utilize the MLVA-15NAU assay for genotyping Brucella
isolates in our reference lab at the CDC and prefer the auto-
mated platform for its reproducibility, the MLVA-15IGM
scheme is used widely in the European community and collab-
orating laboratories. The comparable geographic and in-coun-
try resolution of the two MLVA systems, targeting different
VNTR regions, validates the utility of a combination analysis
system, such as MLVA, for genotyping genetically monomor-
phic bacteria. With the increasing use of multiple MLVA sys-
tems for typing Brucella species and the increasing need to
share data, it would be effective to investigate the discrimina-
tory value of all the currently utilized VNTR markers in these
combination systems by using statistical methods such as prin-
cipal-component analysis in order to establish one streamlined
MLVA system that serves the global need for an epidemiolog-
ical genotyping tool to improve brucellosis surveillance.
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